Two Senators Urge Federal Trade Commission to Finalize Changes to Contact Lens Rule

By Staff
Wednesday, August 16, 2017 12:24 AM WASHINGTON, D.C.—Senators Orrin Hatch (R-Utah) and Richard Blumenthal (D-Conn.) are joining the industry fray over proposed changes to the Contact Lens Rule.

FDA Grants Clearance to Bausch + Lomb’s Boston Xo and Boston XO2 Materials

By Staff
Monday, August 14, 2017 12:18 AM BRIDGEWATER, N.J.—Bausch + Lomb reported that the FDA has granted 510(k) clearance for the therapeutic use of its Boston XO and Boston XO2 materials in treating several ocular surface diseases.

Valeant Reports ‘Organic’ Growth Within B+L Segment During Second Quarter

By Staff
Wednesday, August 9, 2017 12:23 AM LAVAL, Quebec—Valeant Pharmaceuticals International (NYSE: VRX) (TSX: VRX), parent of Bausch + Lomb, reported Tuesday that total revenues in its second quarter declined 8 percent to $2.23 billion from $2.42 billion in the second quarter of 2016. The company attributed the decrease to lower volume and price in its U.S. diversified products segment, among other factors.

Sightbox, a Membership and Supply Service for Contact Lenses, Raises $2.4 Million

By Staff
Monday, July 31, 2017 12:23 AM PORTLAND, Ore.—Startup firm Sightbox, which offers an annual membership-linked supply service for contact lens wearers, recently raised $2.4 million in new funding to support its growth, a spokesman confirmed.

Johnson & Johnson Sees Sales Growth Accelerating in Second Half of 2017

By Staff
Wednesday, July 19, 2017 12:26 AM NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) reported Tuesday that its sales in the second quarter rose 1.9 percent to $18.8 billion, in part a reflection of sales growth within its medical devices business segment (specifically the cardiovascular business and the Acuvue contact lens product line).

Texas AG Reaches Settlement with Online Contact Lens Provider

By Staff
Monday, July 10, 2017 12:30 AM AUSTIN, Texas—Attorney General Ken Paxton of Texas announced that his office has reached a settlement with THEG Inc., which does business as the online contact lens distributor and wholesaler Fine & Clear.

MPG&E Will Distribute Safilens Products in Germany for the Next Five Years

By Staff
Monday, July 3, 2017 12:18 AM STARANZANO, Italy—Safilens announced that MPG&E will be the exclusive distributor of its products in Germany for the next five years.

Three-Year Study Indicates Contact Lens Therapy Effective in Slowing Myopia Progression in Children

By Staff
Monday, June 19, 2017 12:15 AM LIVERPOOL, England —A new contact lens therapy has significant potential to address the rising prevalence of myopia (nearsightedness) in children, according to the results of study outcomes presented here at the British Contact Lens Association Clinical Conference, according to an announcement by CooperVision.

Updated: Connecticut Senate Approves Legislation That Sets Restrictions on CL Rx's Derived from Online Tests

By Staff
Wednesday, June 7, 2017 4:25 PM HARTFORD, Conn.—In the final hours of the 2017 legislative regular session, the Senate in Connecticut voted unanimously late Tuesday night to approve a bill that will limit the use of some new technologies in issuing or refilling prescriptions for contact lenses.

Coalition for Vision Safety Members Meet With FTC to Discuss Contact Lens Rule

By Staff
Friday, May 26, 2017 12:24 AM WASHINGTON—Several member companies of the Coalition for Patient Vision Safety participated in a meeting earlier this week with Federal Trade Commission (FTC) acting chairman Maureen Ohlhausen to discuss the FTC’s proposed changes to the Contact Lens Rule.

AOA and J&J Executives Advocate for Optometry and Patient Safety in Capitol Hill Meetings

By Staff
Friday, May 19, 2017 12:27 AM WASHINGTON, D.C.—Industry leaders visited Capitol Hill this week to deliver a message to Congress about eyecare, patient safety and the importance of “in-person vision care” provided by optometrists.

Valeant Reports First-Quarter Results and Raises Full-Year Adjusted Earnings Guidance Range

By Staff
Wednesday, May 10, 2017 12:26 AM LAVAL, Quebec—Valeant Pharmaceuticals International Inc. (NYSE: VRX) (TSX: VRX), parent company of Bausch + Lomb, reported Tuesday that divestiture efforts enabled the company to reduce its debt by $1.3 billion in the first quarter of 2017 and by $3.6 billion overall since the end of the first quarter of 2016.

Bausch + Lomb Names Gordon to Oversee U.S. Vision Care Business

By Staff
Friday, March 31, 2017 12:30 AM BRIDGEWATER, N.J.— Bausch + Lomb, a unit of Valeant Pharmaceuticals International, Thursday announced several changes to its U.S. management team that it said are "designed to improve operational efficiencies and foster potential synergies to drive growth."

Visioneering Technologies Successfully Lists on ASX

By Staff
Friday, March 31, 2017 12:23 AM ATLANTA—Visioneering Technologies (ASX:VTI), the maker of NaturalVue Multifocal 1 Day contact lenses, announced that it is now listed on the Australian Securities Exchange after raising $33.3 million following the close of its initial public offer.

CooperVision Revises Unilateral Pricing Policy (UPP) On Some Products

By Staff
Wednesday, March 29, 2017 12:33 AM PLEASANTON, Calif.— CooperVision, a unit of The Cooper Cos. (NYSE:COO), is the latest contact lens company to make changes to its Unilateral Pricing Policy (UPP).
Loading...